DavidMcCallMD

Clinical Trials

• A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2022 Oct 05

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Impact Of Muscle Vibration On Gait Control Start of enrollment: 2021 Oct 04

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia Start of enrollment: 2023 Jul 14

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias Start of enrollment: 2024 Oct 31

  Not yet recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias Start of enrollment: 2024 Dec 31

  Not yet recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Join now to see all